Dawnrays Pharmaceutical (Holdings) Limited
http://en.dawnrays.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Dawnrays Pharmaceutical (Holdings) Limited
Hasten Joins China's PCSK9 Race With In-Licensing, Commercialization Capabilities
Chinese firm Hasten has gained greater China rights to LIB Therapeutics’ lerodalcibep for hypercholesterolemia and believes its bet on the unique PCSK9-binding small protein will be backed by strong commercialization capability, the company says in an interview with Scrip.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Dawnrays International Company Limited, Dawnrays International Co., Ltd., Dawnrays Biotechnology Capital (Asia) Ltd., Suzhou Dawnrays Pharmaceutical Co., Ltd., Suzhou Dawnrays Pharmaceutical Science and Technology Co., Ltd., Dawnrays (Nantong) Pharmaceutical Science and Technology Co., Ltd., Ltd., Dawnrays Pharma (Hong Kong) Limited, Fujian Dawnrays Pharmaceutical Co., Ltd., and Lanzhou Dawnrays Pharmaceutical Co., Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Dawnrays Pharmaceutical (Holdings) Limited
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice